‪Douglas Lorne Arnold, MD, FRCP(C)‬

Citeras av

	Alla	Sedan 2020
Citat	61113	21371
h-index	127	66
i10-index	415	279

4400

2200

1100

3300

19911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025163 145 178 225 306 291 450 521 713 812 1076 1134 1076 1173 1356 1232 1278 1342 1330 1403 1366 1705 1983 2206 2376 2686 3093 3162 3446 3670 4320 4303 4184 4220 618

Offentlig åtkomst

Visa alla

97 artiklar

29 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Amit Bar-OrProfessor, University of PennsylvaniaVerifierad e-postadress på pennmedicine.upenn.edu
Sridar Narayanan, PhDAssistant Professor: Department of Neurology and Neurosurgery, McGill UniversityVerifierad e-postadress på mcgill.ca
Paul M. MatthewsEdmond and Lily Safra Chair, Professor of Clinical Neurosciences, Imperial College LondonVerifierad e-postadress på imperial.ac.uk
D. Louis CollinsProfessor of Biomedical Engineering and Neurology & Neurosurgery, McGill UniversityVerifierad e-postadress på mcgill.ca
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Verifierad e-postadress på unisi.it
Gavin GiovannoniQueen Mary University of LondonVerifierad e-postadress på giovannoni.net
Jerry S Wolinsky, MDEmeritus Professor in Neurology, McGovern Medical School, UTHealth, The University of Texas HealthVerifierad e-postadress på uth.tmc.edu
Zografos CaramanosMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill UniversityVerifierad e-postadress på mcgill.ca
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMP, BrazilVerifierad e-postadress på unicamp.br
Jeffrey A CohenCleveland ClinicVerifierad e-postadress på ccf.org
Robert J FoxMellen Center for Multiple Sclerosis, Cleveland ClinicVerifierad e-postadress på ccf.org
eric shoubridgeProfessor, Human Genetics, McGill UniversityVerifierad e-postadress på ericpc.mni.mcgill.ca
Li Min LiProfessor of Neurology, Faculty of Medical Sciences at University of CampinasVerifierad e-postadress på fcm.unicamp.br
Robert A BrownUniversity of Calgary; Montreal Neurological Institute; ShadowLab Research Inc.Verifierad e-postadress på shadowlabresearch.com
Bruce PikeCAIP Chair in Healthy Brain Aging, Head of Image Science, Professor - U of CalgaryVerifierad e-postadress på ucalgary.ca
John G. SledSenior Scientist, Hospital for Sick Children / Professor, University of TorontoVerifierad e-postadress på utoronto.ca
Emmanuelle WaubantProfessor of Neurology and PediatricsVerifierad e-postadress på ucsf.edu
Colm ElliottNeuroRx ResearchVerifierad e-postadress på neurorx.com
Alasdair ColesUniversity of CambridgeVerifierad e-postadress på medschl.cam.ac.uk
Tal ArbelProfessor of Electrical & Computer Engineering, McGill UniversityVerifierad e-postadress på cim.mcgill.ca

Följ

Douglas Lorne Arnold, MD, FRCP(C)

James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill

Verifierad e-postadress på mcgill.ca - Startsida

Magnetic Resonance Imaging Neurological Disorders Multiple Sclerosis Alzheimer's Disease


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008	2857	2008
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... N Engl J Med 376 (3), 209-220, 2017	2125	2017
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012	2123	2012
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... N Engl J Med 376 (3), 221-234, 2017	2041	2017
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ... The Lancet 380 (9856), 1819-1828, 2012	1325	2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ... The lancet 380 (9856), 1829-1839, 2012	1306	2012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ... Lancet 391 (10127), 1263-1273, 2018	1075	2018
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ... Archives of neurology 58 (1), 65-70, 2001	685	2001
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ... Nature medicine 2 (3), 1996	682	1996
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ... Brain 121 (Pt 8), 1469-1477, 1998	629	1998
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008	614	2008
Imaging axonal damage of normal-appearing white matter in multiple sclerosis L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ... Brain 121 (1), 103-113, 1998	608	1998
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ... Brain 126 (2), 462-469, 2003	591	2003
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR DL Arnold, PM Matthews, GK Radda Magnetic resonance in medicine 1 (3), 307-315, 1984	580	1984
Reversible decreases in N‐acetylaspartate after acute brain injury ND Stefano, PM Matthews, DL Arnold Magnetic Resonance in Medicine 34 (5), 721-727, 1995	538	1995
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation AT Nair T, Precup D, Arnold DL Med Image Anal 59, 101557, 2020	520	2020
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ... The Lancet Neurology 13 (7), 657-665, 2014	477	2014
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled … Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model ... JAMA Neurol [PMID: 32511687; Epub: 2020/06/09] 77 (9), 1132-1140, 2020	473*	2020
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins Medical image analysis 17 (1), 1-18, 2013	464	2013
Incidence of acquired demyelination of the CNS in Canadian children B Banwell, J Kennedy, D Sadovnick, DL Arnold, S Magalhaes, ... Neurology 72 (3), 232-239, 2009	422	2009

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare